carbidopa, levodopa and entacapone
- Product NDC
- 55648-782
- 11-digit product format
- 556480782
- Labeler code
- 55648
- Product ID
- 55648-782_9866a9f3-77fb-43ec-b516-2a4dac01e1cc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- carbidopa, levodopa and entacapone
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Wockhardt Limited
- Application
- NDA021485
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2012-02-29
- Marketing end
- 0000-00-00
- Substance
- CARBIDOPA; ENTACAPONE; LEVODOPA
- Active strength
- 13 mg/1; mg/1; mg/1
- Pharmacologic classes
- Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA],Aromatic Amino Acid [EPC],Amino Acids, Aromatic [CS],Catechol O-Methyltransferase Inhibitors [MoA],Catechol-O-Methyltransferase Inhibitor [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 55648-782 | I | Inactivated by FDA | 2026-08-17 | ||
| excluded package | package | 55648-782 | 55648-782-02 | I | Inactivated by FDA | 2026-08-17 | |
| excluded package | package | 55648-782 | 55648-782-03 | I | Inactivated by FDA | 2026-08-17 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 55648-782-03 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 55648-782-02 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 55648-782-03 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 55648-782-02 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 55648-782-03 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 55648-782-02 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 55648-782-03 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 55648-782-02 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 55648-782-03 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 55648-782-02 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 55648-782-03 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 55648-782-02 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 55648-782-03 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 55648-782-02 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 55648-782-03 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 55648-782-02 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 55648-782-03 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 55648-782-02 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 55648-782-03 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 55648-782-02 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 55648-782-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 55648-782-02 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 55648-782-03 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 55648-782-02 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 55648-782-03 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 55648-782-02 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 55648-782-03 | 834df4deac94… | adcc014656a3… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 55648-782-02 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 55648-782-03 | 1332a3947898… | d4bfe170f9cd… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 55648-782-02 | 1332a3947898… | d4bfe170f9cd… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 55648-782-03 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 55648-782-02 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 55648-782-03 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 55648-782-02 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 55648-782-03 | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 55648-782-02 | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 55648-782-03 | 8dfbde2a14a4… | c9ff85d89658… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 55648-782-02 | 8dfbde2a14a4… | c9ff85d89658… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 55648-782-03 | e2bbac7714bc… | 27bdfed8d636… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 55648-782-02 | e2bbac7714bc… | 27bdfed8d636… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021485-001 | STALEVO 50 | CARBIDOPA; ENTACAPONE; LEVODOPA | 12.5MG;200MG;50MG | TABLET / ORAL | AB | RLD, RS | 2003-06-11 |
| N021485-002 | STALEVO 100 | CARBIDOPA; ENTACAPONE; LEVODOPA | 25MG;200MG;100MG | TABLET / ORAL | AB | RLD | 2003-06-11 |
| N021485-003 | STALEVO 150 | CARBIDOPA; ENTACAPONE; LEVODOPA | 37.5MG;200MG;150MG | TABLET / ORAL | AB | RLD | 2003-06-11 |
| N021485-004 | STALEVO 200 | CARBIDOPA; ENTACAPONE; LEVODOPA | 50MG;200MG;200MG | TABLET / ORAL | AB | RLD, RS | 2007-08-02 |
| N021485-005 | STALEVO 75 | CARBIDOPA; ENTACAPONE; LEVODOPA | 18.75MG;200MG;75MG | TABLET / ORAL | AB | RLD | 2008-08-29 |
| N021485-006 | STALEVO 125 | CARBIDOPA; ENTACAPONE; LEVODOPA | 31.25MG;200MG;125MG | TABLET / ORAL | AB | RLD | 2008-08-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N021485-001 | AB |
| N021485-002 | AB |
| N021485-003 | AB |
| N021485-004 | AB |
| N021485-005 | AB |
| N021485-006 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N021485-001 | STALEVO 50 | 12.5MG;200MG;50MG | TABLET / ORAL | AB | RLD, RS | 2003-06-11 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021485-002 | STALEVO 100 | 25MG;200MG;100MG | TABLET / ORAL | AB | RLD | 2003-06-11 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021485-003 | STALEVO 150 | 37.5MG;200MG;150MG | TABLET / ORAL | AB | RLD | 2003-06-11 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021485-004 | STALEVO 200 | 50MG;200MG;200MG | TABLET / ORAL | AB | RLD, RS | 2007-08-02 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021485-005 | STALEVO 75 | 18.75MG;200MG;75MG | TABLET / ORAL | AB | RLD | 2008-08-29 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021485-006 | STALEVO 125 | 31.25MG;200MG;125MG | TABLET / ORAL | AB | RLD | 2008-08-29 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N021485-001 | STALEVO 50 | 12.5MG;200MG;50MG | TABLET / ORAL | AB | RLD, RS | 2003-06-11 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021485-002 | STALEVO 100 | 25MG;200MG;100MG | TABLET / ORAL | AB | RLD | 2003-06-11 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021485-003 | STALEVO 150 | 37.5MG;200MG;150MG | TABLET / ORAL | AB | RLD | 2003-06-11 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021485-004 | STALEVO 200 | 50MG;200MG;200MG | TABLET / ORAL | AB | RLD, RS | 2007-08-02 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021485-005 | STALEVO 75 | 18.75MG;200MG;75MG | TABLET / ORAL | AB | RLD | 2008-08-29 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021485-006 | STALEVO 125 | 31.25MG;200MG;125MG | TABLET / ORAL | AB | RLD | 2008-08-29 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021485-001 | STALEVO 50 | 12.5MG;200MG;50MG | TABLET / ORAL | AB | RLD, RS | 2003-06-11 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021485-002 | STALEVO 100 | 25MG;200MG;100MG | TABLET / ORAL | AB | RLD | 2003-06-11 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021485-003 | STALEVO 150 | 37.5MG;200MG;150MG | TABLET / ORAL | AB | RLD | 2003-06-11 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021485-004 | STALEVO 200 | 50MG;200MG;200MG | TABLET / ORAL | AB | RLD, RS | 2007-08-02 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021485-005 | STALEVO 75 | 18.75MG;200MG;75MG | TABLET / ORAL | AB | RLD | 2008-08-29 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021485-006 | STALEVO 125 | 31.25MG;200MG;125MG | TABLET / ORAL | AB | RLD | 2008-08-29 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N021485-001 | STALEVO 50 | 12.5MG;200MG;50MG | TABLET / ORAL | AB | RLD, RS | 2003-06-11 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021485-002 | STALEVO 100 | 25MG;200MG;100MG | TABLET / ORAL | AB | RLD | 2003-06-11 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021485-003 | STALEVO 150 | 37.5MG;200MG;150MG | TABLET / ORAL | AB | RLD | 2003-06-11 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021485-004 | STALEVO 200 | 50MG;200MG;200MG | TABLET / ORAL | AB | RLD, RS | 2007-08-02 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021485-005 | STALEVO 75 | 18.75MG;200MG;75MG | TABLET / ORAL | AB | RLD | 2008-08-29 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021485-006 | STALEVO 125 | 31.25MG;200MG;125MG | TABLET / ORAL | AB | RLD | 2008-08-29 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021485-001 | STALEVO 50 | 12.5MG;200MG;50MG | TABLET / ORAL | AB | RLD, RS | 2003-06-11 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021485-002 | STALEVO 100 | 25MG;200MG;100MG | TABLET / ORAL | AB | RLD | 2003-06-11 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021485-003 | STALEVO 150 | 37.5MG;200MG;150MG | TABLET / ORAL | AB | RLD | 2003-06-11 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021485-004 | STALEVO 200 | 50MG;200MG;200MG | TABLET / ORAL | AB | RLD, RS | 2007-08-02 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021485-005 | STALEVO 75 | 18.75MG;200MG;75MG | TABLET / ORAL | AB | RLD | 2008-08-29 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021485-006 | STALEVO 125 | 31.25MG;200MG;125MG | TABLET / ORAL | AB | RLD | 2008-08-29 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021485-001 | STALEVO 50 | 12.5MG;200MG;50MG | TABLET / ORAL | AB | RLD, RS | 2003-06-11 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021485-002 | STALEVO 100 | 25MG;200MG;100MG | TABLET / ORAL | AB | RLD | 2003-06-11 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021485-003 | STALEVO 150 | 37.5MG;200MG;150MG | TABLET / ORAL | AB | RLD | 2003-06-11 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021485-004 | STALEVO 200 | 50MG;200MG;200MG | TABLET / ORAL | AB | RLD, RS | 2007-08-02 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021485-005 | STALEVO 75 | 18.75MG;200MG;75MG | TABLET / ORAL | AB | RLD | 2008-08-29 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021485-006 | STALEVO 125 | 31.25MG;200MG;125MG | TABLET / ORAL | AB | RLD | 2008-08-29 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021485-001 | STALEVO 50 | 12.5MG;200MG;50MG | TABLET / ORAL | AB | RLD, RS | 2003-06-11 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021485-002 | STALEVO 100 | 25MG;200MG;100MG | TABLET / ORAL | AB | RLD | 2003-06-11 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021485-003 | STALEVO 150 | 37.5MG;200MG;150MG | TABLET / ORAL | AB | RLD | 2003-06-11 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021485-004 | STALEVO 200 | 50MG;200MG;200MG | TABLET / ORAL | AB | RLD, RS | 2007-08-02 | 03ed91905a0d… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N021485-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021485-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021485-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021485-004 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021485-005 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021485-006 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N021485-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021485-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021485-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021485-004 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021485-005 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021485-006 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021485-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021485-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021485-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021485-004 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021485-005 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021485-006 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N021485-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021485-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021485-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021485-004 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021485-005 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021485-006 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021485-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021485-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021485-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021485-004 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021485-005 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021485-006 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021485-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021485-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021485-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021485-004 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021485-005 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021485-006 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021485-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021485-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021485-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021485-004 | AB | 1 | 03ed91905a0d… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N021485-001 | 6500867 | 2020-06-29 | U-219 | Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021485-001 | 6797732 | 2020-06-29 | Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021485-002 | 6500867 | 2020-06-29 | U-219 | Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021485-002 | 6797732 | 2020-06-29 | Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021485-003 | 6500867 | 2020-06-29 | U-219 | Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021485-003 | 6797732 | 2020-06-29 | Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021485-004 | 6500867 | 2020-06-29 | U-219 | Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021485-004 | 6797732 | 2020-06-29 | Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021485-005 | 6500867 | 2020-06-29 | U-219 | Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021485-005 | 6797732 | 2020-06-29 | Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021485-006 | 6500867 | 2020-06-29 | U-219 | Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021485-006 | 6797732 | 2020-06-29 | Drug product | 74a2ff9319b5… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021485-001 | 6500867 | 2020-06-29 | U-219 | Drug product | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021485-001 | 6797732 | 2020-06-29 | Drug product | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021485-002 | 6500867 | 2020-06-29 | U-219 | Drug product | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021485-002 | 6797732 | 2020-06-29 | Drug product | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021485-003 | 6500867 | 2020-06-29 | U-219 | Drug product | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021485-003 | 6797732 | 2020-06-29 | Drug product | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021485-004 | 6500867 | 2020-06-29 | U-219 | Drug product | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021485-004 | 6797732 | 2020-06-29 | Drug product | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021485-005 | 6500867 | 2020-06-29 | U-219 | Drug product | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021485-005 | 6797732 | 2020-06-29 | Drug product | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021485-006 | 6500867 | 2020-06-29 | U-219 | Drug product | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021485-006 | 6797732 | 2020-06-29 | Drug product | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021485-001 | 6500867 | 2020-06-29 | U-219 | Drug product | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021485-001 | 6797732 | 2020-06-29 | Drug product | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021485-002 | 6500867 | 2020-06-29 | U-219 | Drug product | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021485-002 | 6797732 | 2020-06-29 | Drug product | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021485-003 | 6500867 | 2020-06-29 | U-219 | Drug product | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021485-003 | 6797732 | 2020-06-29 | Drug product | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021485-004 | 6500867 | 2020-06-29 | U-219 | Drug product | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021485-004 | 6797732 | 2020-06-29 | Drug product | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021485-005 | 6500867 | 2020-06-29 | U-219 | Drug product | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021485-005 | 6797732 | 2020-06-29 | Drug product | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021485-006 | 6500867 | 2020-06-29 | U-219 | Drug product | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021485-006 | 6797732 | 2020-06-29 | Drug product | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021485-001 | 6500867 | 2020-06-29 | U-219 | Drug product | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021485-001 | 6797732 | 2020-06-29 | Drug product | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021485-002 | 6500867 | 2020-06-29 | U-219 | Drug product | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021485-002 | 6797732 | 2020-06-29 | Drug product | 3f01610625f2… |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 5ce6fab2-d006-4589-8ba0-02cee499cc60 | Product name | 2 | 20260128 |
| ebf3b793-6fcd-797b-9d2e-c3faf6d29442 | Product name | 5 | 20251106 |
| 162160fe-5ea6-4f9d-aa38-c4b780c57046 | Product name | 1 | 20250515 |
| 0e5ae331-9620-4d1f-8061-7c437c7f1c42 | Product name | 1 | 20250312 |
| 028fdaca-77da-0dfe-e445-7dfc440fc97e | Product name | 4 | 20250224 |
| 7d015b89-35e8-b484-e5db-c0c44814f63c | Product name | 7 | 20241218 |
| 6a098371-84f5-7ced-0ac5-ed90d535b476 | Product name | 6 | 20220927 |
| de702a02-e9c0-4daf-9101-e44f2c0d4e66 | Product name | 1 | 20220609 |
| 681917df-580c-4199-896d-b739fbb25ed3 | Product name | 1 | 20190412 |
| 7d015b89-35e8-b484-e5db-c0c44814f63c | Product name | 4 | 20171212 |
| 1fa100ae-9ab3-4df0-afe7-33ab01fd4a41 | Product name | 1 | 20150313 |
| 88839c8d-b65b-4a50-997b-4c74539855ff | Product name | 1 | 20150313 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55648-782-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-2c26-f424-e053-dadaa90a57ce | Carbidopa, Levodopa and Entacapone Tablets |
| 55648-782-03 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-2c26-f424-e053-dadaa90a57ce | Carbidopa, Levodopa and Entacapone Tablets |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55648-782-02 | carbidopa, levodopa and entacapone | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 3 | |
| 55648-782-03 | carbidopa, levodopa and entacapone | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 3 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Carbidopa, Levodopa, and Entacapone | CARBIDOPA, LEVODOPA, AND ENTACAPONE | Sandoz Inc | 9c16c0e0-3b97-486b-b7d5-579f5853e2c5 | 2026-03-19 | Warnings, Adverse reactions | 021485 NDA021485 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 403850 | carbidopa 12.5 MG / levodopa 50 MG / entacapone 200 MG Oral Tablet | PSN | dabb7f5d-03b3-4d46-951a-e41a1f8d69cc | 3 |
| 810090 | carbidopa 18.75 MG / levodopa 75 MG / entacapone 200 MG Oral Tablet | PSN | dabb7f5d-03b3-4d46-951a-e41a1f8d69cc | 3 |
| 403851 | carbidopa 25 MG / levodopa 100 MG / entacapone 200 MG Oral Tablet | PSN | dabb7f5d-03b3-4d46-951a-e41a1f8d69cc | 3 |
| 810083 | carbidopa 31.25 MG / levodopa 125 MG / entacapone 200 MG Oral Tablet | PSN | dabb7f5d-03b3-4d46-951a-e41a1f8d69cc | 3 |
| 403852 | carbidopa 37.5 MG / levodopa 150 MG / entacapone 200 MG Oral Tablet | PSN | dabb7f5d-03b3-4d46-951a-e41a1f8d69cc | 3 |
| 730988 | carbidopa 50 MG / levodopa 200 MG / entacapone 200 MG Oral Tablet | PSN | dabb7f5d-03b3-4d46-951a-e41a1f8d69cc | 3 |
| 403850 | carbidopa 12.5 MG / entacapone 200 MG / levodopa 50 MG Oral Tablet | SCD | dabb7f5d-03b3-4d46-951a-e41a1f8d69cc | 3 |
| 810090 | carbidopa 18.75 MG / entacapone 200 MG / levodopa 75 MG Oral Tablet | SCD | dabb7f5d-03b3-4d46-951a-e41a1f8d69cc | 3 |
| 403851 | carbidopa 25 MG / entacapone 200 MG / levodopa 100 MG Oral Tablet | SCD | dabb7f5d-03b3-4d46-951a-e41a1f8d69cc | 3 |
| 810083 | carbidopa 31.25 MG / entacapone 200 MG / levodopa 125 MG Oral Tablet | SCD | dabb7f5d-03b3-4d46-951a-e41a1f8d69cc | 3 |
| 403852 | carbidopa 37.5 MG / entacapone 200 MG / levodopa 150 MG Oral Tablet | SCD | dabb7f5d-03b3-4d46-951a-e41a1f8d69cc | 3 |
| 730988 | carbidopa 50 MG / entacapone 200 MG / levodopa 200 MG Oral Tablet | SCD | dabb7f5d-03b3-4d46-951a-e41a1f8d69cc | 3 |
| 403850 | Carbidopa 12.5 MG / entacapone 200 MG / L-DOPA 50 MG Oral Tablet | SY | dabb7f5d-03b3-4d46-951a-e41a1f8d69cc | 3 |
| 810090 | Carbidopa 18.75 MG / entacapone 200 MG / L-DOPA 75 MG Oral Tablet | SY | dabb7f5d-03b3-4d46-951a-e41a1f8d69cc | 3 |
| 403851 | Carbidopa 25 MG / entacapone 200 MG / L-DOPA 100 MG Oral Tablet | SY | dabb7f5d-03b3-4d46-951a-e41a1f8d69cc | 3 |
| 810083 | Carbidopa 31.25 MG / entacapone 200 MG / L-DOPA 125 MG Oral Tablet | SY | dabb7f5d-03b3-4d46-951a-e41a1f8d69cc | 3 |
| 403852 | Carbidopa 37.5 MG / entacapone 200 MG / L-DOPA 150 MG Oral Tablet | SY | dabb7f5d-03b3-4d46-951a-e41a1f8d69cc | 3 |
| 730988 | Carbidopa 50 MG / entacapone 200 MG / L-DOPA 200 MG Oral Tablet | SY | dabb7f5d-03b3-4d46-951a-e41a1f8d69cc | 3 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 55648-782-02 | 55648078202 | 100 in 1 BOTTLE | Historical |
| 55648-782-03 | 55648078203 | 500 in 1 BOTTLE | Historical |